

Zepbound is one of the most talked-about weight loss injections in the US. The drug works by suppressing your appetite and slowing digestion, helping people consume fewer calories.
Currently, Zepbound isn’t available in Thailand under that brand name. The good news is that although Zepbound is not sold in Thailand, its active ingredient, tirzepatide, is available as Mounjaro. If you're searching for Zepbound in Thailand, Mounjaro is the medication you're looking for.
Zepbound is a prescription weight loss medication manufactured by Eli Lilly. It contains tirzepatide as its active ingredient and is currently only available as a branded medicine, with no generic version.
The medication is administered as a once-weekly injection, with the dose increased gradually over time to help minimise side effects and allow your body to adjust to treatment.
Tirzepatide belongs to a newer class of medicines that activates both the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. These hormones help regulate appetite and blood sugar by reducing hunger, increasing feelings of fullness and slowing the rate at which food leaves the stomach.
When combined with a healthy diet and regular physical activity, tirzepatide can help eligible adults with obesity or who are overweight achieve significant and sustainable weight loss.

No, Zepbound is not currently marketed in Thailand. In the United States, Eli Lilly sells tirzepatide for chronic weight management under the Zepbound brand. In Thailand, the same manufacturer markets tirzepatide under the Mounjaro brand instead.
Although Mounjaro was originally developed for the treatment of type 2 diabetes, in Thailand it is also commonly prescribed for weight loss in eligible patients. As a result, people searching for Zepbound in Thailand are usually looking for Mounjaro treatment.
Mounjaro is also a once-weekly tirzepatide injection.
In the US, Mounjaro is primarily associated with type 2 diabetes treatment, although it has an effect on appetite and body weight. In Thailand, the drug is commonly prescribed for weight loss, with registered strengths including 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg.
Zepbound and Mounjaro contain the same active ingredient (tirzepatide) and are both manufactured by Eli Lilly. The main difference is how they are marketed and approved in different countries.
Yes. Mounjaro is commonly prescribed for weight loss in Thailand.
Many people ask their doctor about Zepbound after hearing about its popularity in the United States. In Thailand, however, doctors may recommend Mounjaro, which contains the same active ingredient, tirzepatide.
Mounjaro is registered with the Thai FDA and is available in multiple dose strengths. Whether it is suitable for weight loss depends on your individual health, medical history and treatment goals, and should be assessed by a qualified doctor.
Tirzepatide is primarily for:
Tirzepatide is not suitable for:
Seek urgent medical advice if you develop severe or persistent abdominal pain, especially with vomiting, or symptoms of serious dehydration.
Tirzepatide works on specific hormone receptors that regulate appetite and fullness. People taking tirzepatide feel fewer cravings and are more satisfied with smaller portions. It can also slow stomach emptying, so you feel fuller after your meal.
The drug is also known to help with type 2 diabetes, so it can act as a double treatment, supporting weight loss and blood sugar regulation.
Tirzepatide doesn’t act overnight. Weight loss can vary between patients. However, most people notice gradual weight loss over months, especially when combined with lifestyle changes.
Generally, it’s well tolerated. However, some people can experience:
In extreme cases, tirzepatide can lead to inflammation of the pancreas (pancreatitis), low blood sugar (hypoglycemia), a serious allergic reaction, dehydration leading to kidney problems, or gallbladder problems.
Yes. Both medications contain the same active ingredient, tirzepatide, and are manufactured by Eli Lilly. The main difference is the brand name and approved indication, which vary by country.
Mounjaro and Ozempic are different medications. Mounjaro contains tirzepatide, while Ozempic contains semaglutide. The most suitable treatment depends on your medical history, weight loss goals and your doctor's assessment.
Yes. Mounjaro is a prescription-only medication and should only be used under the guidance of a licensed medical provider. You can consult a doctor online through EDD Health and have Mounjaro conveniently delivered to your home.
Zepbound is not currently available in Bangkok under that brand name. However, Mounjaro, which contains the same active ingredient (tirzepatide), is available in Thailand. If you're looking for Zepbound, you can consult a doctor online on the EDD Health platform to determine whether Mounjaro is suitable for you.
